How to Fix a Drug Scandal

Plot

Episodes 1–2: The chemists

Massachusetts, early 2010s. Inside the state's drug labs, bench chemists test seized substances, and their one-word conclusions, cocaine or not, decide prosecutions. The first scandal breaks in August 2012, when Annie Dookhan, a chemist at the Hinton state laboratory in Boston, is caught forging test results, declaring drugs present in samples she never tested, a practice known as dry-labbing. Dookhan had been the lab's superstar, processing an impossible number of samples a day, and prosecutors had leaned on her speed for years. Her arrest in September 2012 sends a shock through the courts: every conviction resting on her work is suddenly in doubt, and there are tens of thousands of them.

The second blow lands six months later. In January 2013, Sonja Farak, a 35-year-old chemist at a lab near Amherst, is arrested. The series' most memorable stretch unspools from there: Farak, tasked with testing the drugs seized from arrestees, had begun consuming the evidence itself, sampling the cocaine, heroin, and eventually crack cocaine in the lab over years, taking breaks on the job to smoke crack. The two women did not know each other and had never worked together. The coincidence of two chemists independently corrupting the same system within months is the engine of the series' first half.

Episodes 3–4: The cover-up

The back half turns from the crimes to the response. Massachusetts had already been through one chemist scandal in 2012, and officials, prosecutors, and the courts treated Farak's arrest as a contained problem, a matter of a handful of cases. Behind closed doors, the state knew otherwise: prosecutors and the attorney general's office held Farak's own grand jury testimony and records showing the scope of her drug use in the lab, evidence that the problem reached back years and touched thousands of prosecutions. That evidence was not turned over to defense attorneys as the law required.

The payoff of the four hours is the slow exposure of this suppression. Defense lawyers dig up what the state sat on, and a judge finds that prosecutors withheld exculpatory material, a Brady violation (prosecutors illegally withholding evidence favorable to the defense) on a systemic scale. The consequences cascade: prosecutions collapse, and the courts ultimately move toward dismissing tens of thousands of drug convictions, with estimates of the affected cases running from around 20,000 to as high as 36,000. The series ends on the question of its title: the scandal was not fixed, it was compounded, and the people who fixed the blame were almost never the people who fixed the damage.

The highlight of the series is Farak's grand jury testimony, staged through re-creations with an actress speaking her actual words, intercut with interviews with Farak's family, who speak about her for the first time. Hearing the chemist describe, in her own measured voice, the years of taking drugs from the evidence she was certifying, while her parents and siblings describe the woman they thought they knew, gives the scandal a face and a voice at the exact moment the state is trying to make the whole affair go away quietly. It is the point where the series stops being a procedural and becomes an indictment.

Characters

• Sonja Farak, the chemist at the Amherst-area drug lab who used the evidence in her custody for years before her January 2013 arrest. The series re-creates her grand jury testimony and includes her family's first on-camera interviews.
• Annie Dookhan, the Boston lab chemist who dry-labbed tens of thousands of samples and was arrested in September 2012. Her speed made her indispensable to prosecutors, and her fraud unraveled everything she touched.
• Erin Lee Carr, the director, whose interviews with attorneys, experts, and officials carry the investigation of the state's response in the back half.
• The defense attorneys and prosecutors of Massachusetts, whose conflicting accounts of who knew what, and when, form the spine of the final episodes.

Interpretations and controversies

Critics split over the series' choices. RogerEbert.com argued that Carr buried a fascinating story under "camera tricks, flashy recreations, clipped interview soundbites, frustrating structure," while Collider found too little exploration of the possible cover-up beyond restating the facts and too much effort spent humanizing Farak and Dookhan. Vox countered that the series' real thesis, that justice-system breakdowns are never the fault of one person but of many small parts failing at once, lands even if it arrives late. The central controversy the series itself raises, whether Massachusetts officials deliberately suppressed evidence to protect convictions, is left to viewers to weigh.

Sequels, spin-offs, and adaptations

None. The story continued off-screen: both Dookhan and Farak had already served their prison sentences by the time the series premiered, and the mass dismissal of tainted convictions proceeded in the Massachusetts courts after the series aired.